Neuromodulation for Spinal Cord Injury
Trial Summary
The trial excludes participants who are taking drugs that affect the central nervous system and lower the seizure threshold, like antipsychotic drugs. If you are on such medications, you may not be eligible to participate.
Research shows that repetitive transcranial magnetic stimulation (rTMS) can improve motor function and gait in people with spinal cord injuries. Studies have highlighted its potential to enhance motor recovery and reduce muscle stiffness, suggesting it could be a promising treatment for spinal cord injury.
12345Repetitive transcranial magnetic stimulation (rTMS) has been used safely in both healthy individuals and those with neuropsychiatric conditions since the 1990s. Safety guidelines have been established and updated over the years, with the most recent in 2021, to ensure safe application, focusing on potential adverse events and precautions.
23467Repetitive transcranial magnetic stimulation (rTMS) is unique because it is a non-invasive treatment that uses magnetic fields to stimulate nerve cells in the brain, potentially improving motor function and reducing spasticity in spinal cord injury patients. Unlike other treatments, rTMS aims to enhance the brain's ability to reorganize and form new connections, which may help in recovery.
12345Eligibility Criteria
This trial is for adults with or without spinal cord injuries who are interested in participating in a study to improve hand functions. The University at Buffalo aims to understand the connection between the brain, nerves, and muscles.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive rTMS or Sham rTMS with functional and physiological outcomes measured before and after each session
Extended Treatment
Participants receive rTMS with motor training for long-term up to 50 sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment